Childhood Oligodendroglioma — Trials

Childhood Oligodendroglioma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02684058	Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors	completed	Phase 2	151	Novartis PharmaceuticalsINDUSTRY	20	Dec 13, 2023	clinicaltrials
NCT00381797	Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma	completed	Phase 2	97	National Cancer Institute (NCI)NIH	1	Nov 28, 2017	clinicaltrials
NCT01462695	Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma	completed	Phase 2	30	National Cancer Institute (NCI)NIH	3	Aug 27, 2015	clinicaltrials
NCT00042991

Data updated 23 days agoSource updated Dec 13, 2023source: clinicaltrials